Home - News ( United States | United Kingdom | Italy | Germany ) - Football scores

Showing content from https://www.medscape.org/viewarticle/1002337 below:

Maternal Respiratory Syncytial Virus Vaccination and Receipt of Respiratory Syncytial Virus Antibody (Nirsevimab) by Infants Aged <8 Months — United States, April 2024

• Credits Available

  Physicians - maximum of 0.50 AMA PRA Category 1 Credit(s)™

  Nurses - 0.50 ANCC Contact Hour(s) (0.5 contact hours are in the area of pharmacology)

  Pharmacists - 0.50 Knowledge-based ACPE (0.050 CEUs)

  IPCE - 0.50 Interprofessional Continuing Education (IPCE) credit

  You Are Eligible For

This activity is intended for primary care clinicians, obstetrician gynecologists, pediatricians, nurses, pharmacists, and other clinicians who care for pregnant women and infants.

The goal of this activity is for learners to be better able to evaluate the use of the maternal RSV vaccine and nirsevimab in the United States.

Upon completion of this activity, participants will:

• Distinguish guidelines for the prevention of serious RSV illness during infancy
• Assess the attitude and preference of pregnant women for RSV immunization to prevent serious RSV illness during infancy
• Evaluate variables associated with higher uptake of the maternal RSV vaccine and nirsevimab
• Analyze reasons why women did not receive the maternal RSV vaccine or nirsevimab for their infants

Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships.

• Hilda Razzaghi, PhD

  Immunization Services Division
  National Center for Immunization and Respiratory Diseases
  Centers for Disease Control and Prevention
  Atlanta, Georgia

  Disclosures

  Hilda Razzaghi, PhD, has no relevant financial relationships.

• Emma Garacci, MS

  Cherokee Nation Operational Solutions
  Tulsa, Oklahoma

  Disclosures

  Emma Garacci, MS, has no relevant financial relationships.

• Katherine E. Kahn, MPH

  Eagle Health Analytics
  Atlanta, Georgia

  Disclosures

  Katherine E. Kahn, MPH, has no relevant financial relationships.

• Megan C. Lindley, MPH

  Immunization Services Division
  National Center for Immunization and Respiratory Diseases
  Centers for Disease Control and Prevention
  Atlanta, Georgia

  Disclosures

  Megan C. Lindley, MPH, has no relevant financial relationships.

• Jefferson M. Jones, MD

  Coronavirus and Other Respiratory Viruses Division
  National Center for Immunization and Respiratory Diseases
  Centers for Disease Control and Prevention
  Atlanta, Georgia

  Disclosures

  Jefferson M. Jones, MD, has no relevant financial relationships.

• Shannon Stokley, DrPH

  Immunization Services Division
  National Center for Immunization and Respiratory Diseases
  Centers for Disease Control and Prevention
  Atlanta, Georgia

  Disclosures

  Shannon Stokley, DrPH, has no relevant financial relationships.

• Kayla Calhoun, MS

  Immunization Services Division
  National Center for Immunization and Respiratory Diseases
  Centers for Disease Control and Prevention
  Atlanta, Georgia

  Disclosures

  Kayla Calhoun, MS, has no relevant financial relationships.

• Carla L. Black, PhD

  Immunization Services Division
  National Center for Immunization and Respiratory Diseases
  Centers for Disease Control and Prevention
  Atlanta, Georgia

  Disclosures

  Carla L. Black, PhD, has no relevant financial relationships.

• Charles P. Vega, MD

  Health Sciences Clinical Professor of Family Medicine
  University of California, Irvine School of Medicine
  Irvine, California

  Disclosures

  Charles P. Vega, MD, has the following relevant financial relationships:
  Consultant or advisor for: Boehringer Ingelheim Pharmaceuticals, Inc.; GlaxoSmithKline

• Amanda Jett, PharmD, BCACP, CHCP

  Associate Director, Accreditation and Compliance, Medscape Education

  Disclosures

  Amanda Jett, PharmD, BCACP, CHCP, has no relevant financial relationships.

• Leigh Schmidt, MSN, RN, CNE, CHCP

  Associate Director, Accreditation and Compliance, Medscape Education

  Disclosures

  Leigh Schmidt, MSN, RN, CNE, CHCP, has no relevant financial relationships.

In support of improving patient care, Medscape, LLC is jointly accredited with commendation by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

This activity was planned by and for the healthcare team, and learners will receive 0.50 Interprofessional Continuing Education (IPCE) credit for learning and change.

For Physicians

• Medscape, LLC designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  Contact This Provider

For Nurses

• Awarded 0.50 contact hour(s) of nursing continuing professional development for RNs and APNs; 0.50 contact hours are in the area of pharmacology.

  Contact This Provider

For Pharmacists

• Medscape designates this continuing education activity for 0.50 contact hour(s) ( 0.050 CEUs) (Universal Activity Number: JA0007105-0000-25-056-H01-P).

  Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit(s)™, you must receive a minimum score of 75% on the post-test.

Follow these steps to earn CME/CE credit*:

1. Read about the target audience, learning objectives, and author disclosures.
2. Study the educational content online or print it out.
3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate, but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period, you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

RetroSearch is an open source project built by @garambo | Open a GitHub Issue

Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo

HTML: 3.2 | Encoding: UTF-8 | Version: 0.7.3